BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6409834)

  • 1. Specific inhibition of Pseudomonas aeruginosa elastase injected intracorneally in rabbit eyes.
    Kessler E; Spierer A; Blumberg S
    Invest Ophthalmol Vis Sci; 1983 Aug; 24(8):1093-7. PubMed ID: 6409834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth of Pseudomonas aeruginosa and secretion of protease in the presence of the protease inhibitors.
    Kessler E; Safrin M
    Metab Pediatr Syst Ophthalmol; 1982; 6(3-4):331-6. PubMed ID: 6820960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by phosphoramidon of Pseudomonas aeruginosa elastase injected intracorneally in rabbit eyes.
    Kessler E; Spierer A
    Curr Eye Res; 1984 Aug; 3(8):1075-8. PubMed ID: 6435958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of 2-mercaptoacetyl-L-phenylalanyl-L-leucine, a specific inhibitor of Pseudomonas aeruginosa elastase, on experimental Pseudomonas keratitis in rabbit eyes.
    Spierer A; Kessler E
    Curr Eye Res; 1984 Apr; 3(4):645-50. PubMed ID: 6562000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Pseudomonas aeruginosa elastase and Pseudomonas keratitis using a thiol-based peptide.
    Burns FR; Paterson CA; Gray RD; Wells JT
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2065-9. PubMed ID: 2127341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.
    Barletta JP; Angella G; Balch KC; Dimova HG; Stern GA; Moser MT; van Setten GB; Schultz GS
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):20-8. PubMed ID: 8550324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro inhibition of Pseudomonas aeruginosa elastase by metal-chelating peptide derivatives.
    Kessler E; Israel M; Landshman N; Chechick A; Blumberg S
    Infect Immun; 1982 Nov; 38(2):716-23. PubMed ID: 6815099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effect of immunization with OEP, protease toxoid and elastase toxoid on corneal ulcers in mice due to Pseudomonas aeruginosa infection.
    Hirao Y; Homma JY
    Jpn J Exp Med; 1978 Feb; 48(1):41-51. PubMed ID: 97424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of galardin on collagen degradation by Pseudomonas aeruginosa.
    Hao JL; Nagano T; Nakamura M; Kumagai N; Mishima H; Nishida T
    Exp Eye Res; 1999 Dec; 69(6):595-601. PubMed ID: 10620388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxycycline in the management of pseudomonas corneal melting: two case reports and a review of the literature.
    McElvanney AM
    Eye Contact Lens; 2003 Oct; 29(4):258-61. PubMed ID: 14555906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
    Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
    Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of phosphoramidon on protection against corneal ulcer caused by elastase and protease from Pseudomonas aeruginosa.
    Kawaharajo K; Homma JY; Aoyagi T; Umezawa H
    Jpn J Exp Med; 1982 Oct; 52(5):271-2. PubMed ID: 6820397
    [No Abstract]   [Full Text] [Related]  

  • 13. Bacterial proteases and adherence of Pseudomonas aeruginosa to mouse cornea.
    Gupta SK; Masinick SA; Hobden JA; Berk RS; Hazlett LD
    Exp Eye Res; 1996 Jun; 62(6):641-50. PubMed ID: 8983946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for TIMP-1 protection against P. aeruginosa-induced corneal ulceration and perforation.
    Kernacki KA; Barrett R; Hazlett LD
    Invest Ophthalmol Vis Sci; 1999 Dec; 40(13):3168-76. PubMed ID: 10586939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaylsis of birefringence during wound healing and remodeling following alkali burns in rabbit cornea.
    Huang Y; Meek KM; Ho MW; Paterson CA
    Exp Eye Res; 2001 Oct; 73(4):521-32. PubMed ID: 11825023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lecithin-bound superoxide dismutase in the prevention of neutrophil-induced damage of corneal tissue.
    Matsumoto K; Shimmura S; Goto E; Saito K; Takeuchi T; Miyajima S; Negi A; Tsubota K
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):30-5. PubMed ID: 9430542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pseudomonas aeruginosa strain isolated from a contact lens-induced acute red eye (CLARE) is protease-deficient.
    Estrellas PS; Alionte LG; Hobden JA
    Curr Eye Res; 2000 Mar; 20(3):157-65. PubMed ID: 10694889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
    Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.